erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Pityriasis Lichenoides D017514 2 associated lipids
Postgastrectomy Syndromes D011178 2 associated lipids
Elephantiasis D004604 2 associated lipids
Mastoiditis D008417 2 associated lipids
Herpes Genitalis D006558 2 associated lipids
Ehrlichiosis D016873 2 associated lipids
Hearing Loss, Functional D006315 2 associated lipids
Onychomycosis D014009 2 associated lipids
Tooth Fractures D014082 2 associated lipids
Rickettsiaceae Infections D012288 2 associated lipids
Pneumonia, Staphylococcal D011023 2 associated lipids
Gardner Syndrome D005736 2 associated lipids
Nasopharyngeal Diseases D009302 2 associated lipids
Bile Reflux D001655 2 associated lipids
Wounds, Gunshot D014948 2 associated lipids
Granuloma, Lethal Midline D006103 2 associated lipids
Rubella D012409 2 associated lipids
Seroma D049291 2 associated lipids
Furunculosis D005667 2 associated lipids
Porphyrias D011164 2 associated lipids
Periodontal Abscess D010508 2 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Pancreatic Fistula D010185 2 associated lipids
Communicable Diseases, Emerging D021821 3 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Heart Block D006327 3 associated lipids
Bursitis D002062 3 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Diarrhea, Infantile D003968 3 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Legionellosis D007876 3 associated lipids
Jejunal Diseases D007579 3 associated lipids
Pleuropneumonia D011001 3 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Hypersplenism D006971 3 associated lipids
Pityriasis D010915 3 associated lipids
Tourette Syndrome D005879 3 associated lipids
Syphilis, Congenital D013590 3 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Gangrene D005734 3 associated lipids
Pulmonary Emphysema D011656 3 associated lipids
Typhus, Endemic Flea-Borne D014437 3 associated lipids
Ileus D045823 3 associated lipids
Keratoconjunctivitis D007637 3 associated lipids
Otorhinolaryngologic Diseases D010038 3 associated lipids
Acneiform Eruptions D017486 3 associated lipids
Acalculous Cholecystitis D042101 3 associated lipids
Moraxellaceae Infections D045828 3 associated lipids
Sporotrichosis D013174 3 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Altomare G et al. Treatment of bullous pemphigoid with erythromycin: a reappraisal. 1999 Oct-Nov Eur J Dermatol pmid:10610238
Czeizel AE et al. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. 1999 Nov-Dec Reprod. Toxicol. pmid:10613401
Urmösi J [Thrombophlebitis of the sinus cavernosus]. 1975 Stomatol DDR pmid:1061410
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999 Sex Transm Infect pmid:10616372
National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases) 1999 Sex Transm Infect pmid:10616373
National guideline for the management of early syphilis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999 Sex Transm Infect pmid:10616379
National guideline for the management of lymphogranuloma venereum. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999 Sex Transm Infect pmid:10616382
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999 Sex Transm Infect pmid:10616383
Chieppa DM et al. Effects of erythromycin on human colonic circular muscle in idiopathic chronic constipation. 2000 Eur. J. Clin. Invest. pmid:10620004
Novikova SI et al. Introduction of a mini-gene encoding a five-amino acid peptide confers erythromycin resistance on Bacillus subtilis and provides temporary erythromycin protection in Proteus mirabilis. 2000 FEMS Microbiol. Lett. pmid:10620668
Desaki M et al. Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. 2000 Biochem. Biophys. Res. Commun. pmid:10623585
Kdesh A et al. Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia. 1999 South. Med. J. pmid:10624910
Gallardo MA and Thomas I Hypersensitivity reaction to erythromycin. 1999 Cutis pmid:10626100
Lagrou K et al. Macrolide resistance in Belgian Streptococcus pneumoniae. 2000 J. Antimicrob. Chemother. pmid:10629023
García Sánchez MJ et al. [Bacterial resistances]. 1999 Aten Primaria pmid:10630037
Sullivan S et al. Stevens-Johnson syndrome secondary to erythromycin. 1999 Ann Pharmacother pmid:10630839
Trinkle R Comment: evaluation of the clinical and financial impact of intravenous erythromycin therapy in hospitalized patients. 1999 Ann Pharmacother pmid:10630842
Puri SK and Singh N Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. 2000 Exp. Parasitol. pmid:10631075
Weston WL and Morelli JG Steroid rosacea in prepubertal children. 2000 Arch Pediatr Adolesc Med pmid:10632252
Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. 1999 MMWR Morb. Mortal. Wkly. Rep. pmid:10634345
Nasrin D et al. Antibiotic resistance in Streptococcus pneumoniae isolated from children. 1999 J Paediatr Child Health pmid:10634983
Martínez-Maldonado M Postinfectious glomerulonephritis. 2000 Am. J. Kidney Dis. pmid:10636819
Wu YJ Highlights of semi-synthetic developments from erythromycin A. 2000 Curr. Pharm. Des. pmid:10637376
Bajic S et al. Analysis of erythromycin by liquid chromatography/mass spectrometry using involatile mobile phases with a novel atmospheric pressure ionization source. 2000 Rapid Commun. Mass Spectrom. pmid:10637421
Gisby J and Bryant J Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. 2000 Antimicrob. Agents Chemother. pmid:10639346
Brueggemann AB et al. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 2000 Antimicrob. Agents Chemother. pmid:10639382
Honma Y et al. Effect of erythromycin on Shigella infection of Caco-2 cells. 2000 FEMS Immunol. Med. Microbiol. pmid:10640609
Sharma PK et al. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. 2000 J. Am. Acad. Dermatol. pmid:10642679
Santos R et al. Bacillary angiomatosis by Bartonella quintana in an HIV-infected patient. 2000 J. Am. Acad. Dermatol. pmid:10642694
Lebwohl M et al. Clinically significant therapeutic interactions for the practicing dermatologist. 1999 Adv Dermatol pmid:10643493
Heidenreich A et al. Gastroparesis after retroperitoneal surgery successfully treated with erythromycin. 2000 J. Urol. pmid:10647677
Medhus AW et al. Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. 2000 Aliment. Pharmacol. Ther. pmid:10651665
Mackinnon AM The problem of intrahepatic cholestasis. 1975 Aust N Z J Med pmid:1065291
Tsutsumi M et al. Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats. 2000 Carcinogenesis pmid:10657965
Allevi P et al. A new convenient transformation of erythromycin A into clarithromycin. 1999 Bioorg. Med. Chem. pmid:10658579
Nakahara S et al. Bronchial amyloidosis successfully treated with low-dose long-term erythromycin therapy. 1999 Kurume Med J pmid:10659597
From the Centers for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. 2000 JAMA pmid:10659863
Descheemaeker P et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. 2000 J. Antimicrob. Chemother. pmid:10660498
Wilkinson B et al. Novel octaketide macrolides related to 6-deoxyerythronolide B provide evidence for iterative operation of the erythromycin polyketide synthase. 2000 Chem. Biol. pmid:10662692
Tang L et al. Formation of functional heterologous complexes using subunits from the picromycin, erythromycin and oleandomycin polyketide synthases. 2000 Chem. Biol. pmid:10662693
Moutard I et al. In vitro effects of spiramycin and dirithromycin on IL1 beta production by human LPS-stimulated mononuclear cells. 1999 Sep-Oct Therapie pmid:10667098
Mordi MN et al. Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy. 2000 J. Med. Chem. pmid:10669574
Munroe CO and Lazarus TL Prevention of infective endocarditis. 1976 Dent J pmid:1067255
Gibson J et al. Oral staphylococcal mucositis: A new clinical entity in orofacial granulomatosis and Crohn's disease. 2000 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:10673652
Holen S Antibiotics used traditionally in periodontal therapy. 1976 J. Periodontol. pmid:1067412
Biddle JW and Thornsberry C In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae. 1979 Antimicrob. Agents Chemother. pmid:106776
Kohri K et al. Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages. 2000 Eur. Respir. J. pmid:10678622
Poyart C et al. Characterization of the Tn916-like transposon Tn3872 in a strain of abiotrophia defectiva (Streptococcus defectivus) causing sequential episodes of endocarditis in a child. 2000 Antimicrob. Agents Chemother. pmid:10681362
Tang X and Cheng D [The value of erythromycin pleurodesis in the treatment of malignant pleural effusions]. 1997 Hua Xi Yi Ke Da Xue Xue Bao pmid:10683963
Berg TG et al. Ureaplasma/Mycoplasma-infected amniotic fluid: pregnancy outcome in treated and nontreated patients. 1999 J Perinatol pmid:10685238